Advertisement

Effect of Shorter Door-to-Balloon Times Over 20 Years on Outcomes of Patients With Anterior ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

      Cardiovascular disease remains the most common cause of mortality. We studied the change in outcomes for anterior ST-elevation myocardial infarction (STEMI) between 1995 and 2014. Over the past 20 years, 1,658 patients presenting to our center with anterior STEMI underwent primary percutaneous coronary intervention within 12 hours of presentation. We divided these into 4 quartiles, 1995 to 1999 (n = 312), 2000 to 2004 (n = 408), 2005 to 2009 (n = 428), and 2010 to 2014 (n = 510). Across the 4 quartiles, mean age decreased (64.4, 62, 60.3, and 60 years, p <0.01). In all groups, there was a significant rise in prevalence of smoking, hypertension, and obesity. The median length of hospital stay decreased (6, 4.4, 4.2, and 3.6 days, p <0.01), as did the median door-to-balloon time (DBT) (217, 194, 135, and 38 minutes, p <0.01). Thirty-day and 1-year mortality improved over time (14.4%, 11.8%, 8.4%, and 7.8%; and 20.5%, 16.4%, 15.9%, and 13.9%) (p = 0.01 both). Also, 3-year mortality improved (25.3%, 21.6%, 21.3%, and 16.5%, p = 0.02). After adjusting for age, gender, co-morbidities, ejection fraction, clinical shock, and mitral regurgitation, shorter DBT was associated with lower long-term mortality (compared with DBT <60 minutes; 60 to 90 minutes hazard ratio [HR] 1.67, 95% confidence interval [CI] 0.93 to 3.00, p = 0.084; 90 to 120 minutes, HR 1.74, 95% CI 1.02 to 2.95, p = 0.04; >120 minutes, HR 1.91, 95% CI 1.23 to 2.96, p = 0.004). In conclusion, over the past 2 decades, long-term outcomes improved in patients presenting with anterior STEMI associated with shortening of DBT.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lagerqvist B.
        • James S.K.
        • Stenestrand U.
        • Lindbäck J.
        • Nilsson T.
        • Wallentin L.
        Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
        N Engl J Med. 2007; 356: 1009-1019
        • Cayla G.
        • Silvain J.
        • O'Connor S.A.
        • Collet J.P.
        • Montalescot G.
        An evidence-based review of current anti-platelet options for STEMI patients.
        Int J Cardiol. 2013; : 294-303
        • Kaltoft A.
        • Bøttcher M.
        • Nielsen S.S.
        • Hansen H.-H.T.
        • Terkelsen C.
        • Maeng M.
        • Kristensen J.
        • Thuesen L.
        • Krusell L.R.
        • Kristensen S.D.
        • Andersen H.R.
        • Lassen J.F.
        • Rasmussen K.
        • Rehling M.
        • Nielsen T.T.
        • Bøtker H.E.
        Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial.
        Circulation. 2006; 114: 40-47
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • Benjamin E.J.
        • Berry J.D.
        • Blaha M.J.
        • Dai S.
        • Ford E.S.
        • Fox C.S.
        • Franco S.
        • Fullerton H.J.
        • Gillespie C.
        • Hailpern S.M.
        • Heit J.A.
        • Howard V.J.
        • Huffman M.D.
        • Judd S.E.
        • Kissela B.M.
        • Kittner S.J.
        • Lackland D.T.
        • Lichtman J.H.
        • Lisabeth L.D.
        • Mackey R.H.
        • Magid D.J.
        • Marcus G.M.
        • Marelli A.
        • Matchar D.B.
        • McGuire D.K.
        • Mohler E.R.
        • Moy C.S.
        • Mussolino M.E.
        • Neumar R.W.
        • Nichol G.
        • Pandey D.K.
        • Paynter N.P.
        • Reeves M.J.
        • Sorlie P.D.
        • Stein J.
        • Towfighi A.
        • Turan T.N.
        • Virani S.S.
        • Wong N.D.
        • Woo D.
        • Turner M.B.
        • American Heart Association Statistics Committee and Stroke Statistics Subcommittee
        Heart disease and stroke statistics—2014 update: a report from the American Heart Association.
        Circulation. 2014; 129: e28-e292
        • Chatterjee P.
        • Joynt K.E.
        Do cardiology quality measures actually improve patient outcomes?.
        J Am Heart Assoc. 2014; 3: e000404
        • Williams S.C.
        • Schmaltz S.P.
        • Morton D.J.
        • Koss R.G.
        • Loeb J.M.
        Quality of care in U.S. hospitals as reflected by standardized measures, 2002–2004.
        N Engl J Med. 2005; 353: 255-264
        • Nallamothu B.K.
        • Normand S.-L.T.
        • Wang Y.
        • Hofer T.P.
        • Brush J.E.
        • Messenger J.C.
        • Bradley E.H.
        • Rumsfeld J.S.
        • Krumholz H.M.
        Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study.
        Lancet. 2015; 385: 1114-1122
        • Berger P.B.
        • Ellis S.G.
        • Holmes D.R.
        • Granger C.B.
        • Criger D.A.
        • Betriu A.
        • Topol E.J.
        • Califf R.M.
        Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.
        Circulation. 1999; 100: 14-20
        • Cannon C.P.
        • Gibson C.M.
        • Lambrew C.T.
        • Shoultz D.A.
        • Levy D.
        • French W.J.
        • Gore J.M.
        • Weaver W.D.
        • Rogers W.J.
        • Tiefenbrunn A.J.
        Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.
        JAMA. 2000; 283: 2941-2947
        • McNamara R.L.
        • Wang Y.
        • Herrin J.
        • Curtis J.P.
        • Bradley E.H.
        • Magid D.J.
        • Peterson E.D.
        • Blaney M.
        • Frederick P.D.
        • Krumholz H.M.
        Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.
        J Am Coll Cardiol. 2006; 47: 2180-2186
        • Flynn A.
        • Moscucci M.
        • Share D.
        • Smith D.
        • LaLonde T.
        • Changezi H.
        • Riba A.
        • Gurm H.S.
        Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
        Arch Intern Med. 2010; 170: 1842-1849
        • Menees D.S.
        • Peterson E.D.
        • Wang Y.
        • Curtis J.P.
        • Messenger J.C.
        • Rumsfeld J.S.
        • Gurm H.S.
        Door-to-balloon time and mortality among patients undergoing primary PCI.
        N Engl J Med. 2013; 369: 901-909
        • Dohi T.
        • Maehara A.
        • Brener S.J.
        • Généreux P.
        • Gershlick A.H.
        • Mehran R.
        • Gibson C.M.
        • Mintz G.S.
        • Stone G.W.
        Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).
        Am J Cardiol. 2015; 115: 563-570
        • Philip F.
        • Agarwal S.
        • Bunte M.C.
        • Bunte M.
        • Goel S.S.
        • Tuzcu E.M.
        • Ellis S.
        • Kapadia S.R.
        Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
        Circ Cardiovasc Interv. 2014; 7: 49-61
        • Shishehbor M.H.
        • Amini R.
        • Oliveria L.P.J.
        • Singh I.M.
        • Kelly P.
        • Bhatt D.L.
        • Kapadia S.R.
        • Ellis S.G.
        • Whitlow P.L.
        • Brener S.J.
        Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction.
        JACC Cardiovasc Interv. 2008; 1: 227-232
        • Shishehbor M.H.
        • Filby S.J.
        • Chhatriwalla A.K.
        • Christofferson R.D.
        • Jain A.
        • Kapadia S.R.
        • Lincoff A.M.
        • Bhatt D.L.
        • Ellis S.G.
        Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia.
        JACC Cardiovasc Interv. 2009; 2: 329-336
        • Gurm H.S.
        • Hosman C.
        • Share D.
        • Moscucci M.
        • Hansen B.B.
        Comparative safety of vascular closure devices and manual closure among patients having percutaneous coronary intervention.
        Ann Intern Med. 2013; 159: 660-666
        • Rathod K.S.
        • Jones D.A.
        • Bromage D.I.
        • Gallagher S.M.
        • Rathod V.S.
        • Kennon S.
        • Knight C.
        • Rothman M.T.
        • Mathur A.
        • Smith E.
        • Jain A.K.
        • Archbold R.A.
        • Wragg A.
        Radial primary percutaneous coronary intervention is independently associated with decreased long-term mortality in high-risk ST-elevation myocardial infarction patients.
        J Cardiovasc Med (Hagerstown). 2015; 16: 170-177
        • Komócsi A.
        • Aradi D.
        • Kehl D.
        • Ungi I.
        • Thury A.
        • Pintér T.
        • Di Nicolantonio J.J.
        • Tornyos A.
        • Vorobcsuk A.
        Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction.
        Arch Med Sci. 2014; 10: 203-212
        • Valgimigli M.
        • Saia F.
        • Guastaroba P.
        • Menozzi A.
        • Magnavacchi P.
        • Santarelli A.
        • Passerini F.
        • Sangiorgio P.
        • Manari A.
        • Tarantino F.
        • Margheri M.
        • Benassi A.
        • Sangiorgi M.G.
        • Tondi S.
        • Marzocchi A.
        Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) multicenter registry.
        JACC Cardiovasc Interv. 2012; 5: 23-35
        • Ergelen M.
        • Uyarel H.
        • Altay S.
        • Ayhan E.
        • Isik T.
        • Bacaksiz A.
        • Kemaloğlu T.
        • Gül M.
        • Cicek G.
        • Kul S.
        • Ertas G.
        • Tasal A.
        Prognostic impact of red blood cell transfusion in patients undergoing primary angioplasty for ST elevation myocardial infarction.
        Coron Artery Dis. 2012; 23: 517-522
        • Nikolsky E.
        • Mehran R.
        • Sadeghi H.M.
        • Grines C.L.
        • Cox D.A.
        • Garcia E.
        • Tcheng J.E.
        • Griffin J.J.
        • Guagliumi G.
        • Stuckey T.
        • Turco M.
        • Fahy M.
        • Lansky A.J.
        • Stone G.W.
        Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
        JACC Cardiovasc Interv. 2009; 2: 624-632
        • Jolicoeur E.M.
        • O'Neill W.W.
        • Hellkamp A.
        • Hamm C.W.
        • Holmes D.R.
        • Al-Khalidi H.R.
        • Patel M.R.
        • Van de Werf F.J.
        • Pieper K.
        • Armstrong P.W.
        • Granger C.B.
        Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
        Eur Heart J. 2009; 30: 2575-2583
        • Kim P.
        • Dixon S.
        • Eisenbrey A.B.
        • O'Malley B.
        • Boura J.
        • O'Neill W.
        Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention.
        Clin Cardiol. 2007; 30: II35-II43
        • Kinnaird T.D.
        • Stabile E.
        • Mintz G.S.
        • Lee C.W.
        • Canos D.A.
        • Gevorkian N.
        • Pinnow E.E.
        • Kent K.M.
        • Pichard A.D.
        • Satler L.F.
        • Weissman N.J.
        • Lindsay J.
        • Fuchs S.
        Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.
        Am J Cardiol. 2003; 92: 930-935
        • Welch H.G.
        • Meehan K.R.
        • Goodnough L.T.
        Prudent strategies for elective red blood cell transfusion.
        Ann Intern Med. 1992; 116: 393-402
        • Almac E.
        • Ince C.
        The impact of storage on red cell function in blood transfusion.
        Best Pract Res Clin Anaesthesiol. 2007; 21: 195-208
        • Berezina T.L.
        • Zaets S.B.
        • Morgan C.
        • Spillert C.R.
        • Kamiyama M.
        • Spolarics Z.
        • Deitch E.A.
        • Machiedo G.W.
        Influence of storage on red blood cell rheological properties.
        J Surg Res. 2002; 102: 6-12
        • Doyle B.J.
        • Rihal C.S.
        • Gastineau D.A.
        • Holmes D.R.
        Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice.
        J Am Coll Cardiol. 2009; 53: 2019-2027